Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 279-293 http://medscipublisher.com/index.php/cge 293 Zen Z., Lin P.H., Koh S.B., Stewart K., Haradhvala N., Dedeoglu A.S., Smidt I., Suzuki A., Li D., Thant W., Mueller S., Joseph T., Bossuyt V., Lawrence M., Getz G., and Ellisen L.W., 2023, Abstract 767: genomics and transcriptomics profiling of BRCA mutation carriers revealed the landscape of early pathogenesis of BRCA1/2-associated breast cancer, Cancer Research, 83 (7_Supplement): 767. https://doi.org/10.1158/1538-7445.am2023-767 Zhang X.Y., Zhao W.W., Wei W., You Z.L., Ou X.H., Sun M.M., Yin Y.L., Tang X.Y., Zhao Z., Hu C.M., Liu F.F., Deng J.H., Mao L.L., Zhou D.Y., Ren Y.X., Li X.X., Zhang S.F., Liu C., Geng J.S., Yao G.D., Song B.B., Liu Y.P., Li D.L., Jiang Y.D., Chen Y.B., Zhao Y.S., Yu S.H., and Pang D., 2019, Parallel analyses of somatic mutations in plasma circulating tumor DNA (ctDNA) and matched tumor tissues in early-stage breast cancer, Clinical Cancer Research, 25(21): 6546-6553. https://doi.org/10.1158/1078-0432.CCR-18-4055 PMID: 31350313
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==